CCL
60
2
AKAM
39
7
CSCO
60
3
OMC
55
-3
EXPD
43
4
DD
40
6
KEY
48
2
KO
60
11
PSX
47
3
ORLY
64
2
PPG
44
3
EQT
64
5
EXPE
80
16
EXR
48
8
LB
69
7
MAC
55
12
AAPL
56
3
GE
67
2
IRM
49
5
MAR
35
2
CCL
60
2
AKAM
39
7
CSCO
60
3
OMC
55
-3
EXPD
43
4
DD
40
6
KEY
48
2
KO
60
11
PSX
47
3
ORLY
64
2
PPG
44
3
EQT
64
5
EXPE
80
16
EXR
48
8
LB
69
7
MAC
55
12
AAPL
56
3
GE
67
2
IRM
49
5
MAR
35
2
Financhill
Buy
60

ALNY Quote, Financials, Valuation and Earnings

Last price:
$290.61
Seasonality move :
3.3%
Day range:
$287.77 - $300.90
52-week range:
$141.98 - $304.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.50x
P/B ratio:
560.95x
Volume:
1.8M
Avg. volume:
849.4K
1-year change:
98.42%
Market cap:
$37.6B
Revenue:
$2.2B
EPS (TTM):
-$2.17

Alnylam Pharmaceuticals SEC Filings

Company Filed Form Type Description
ALNY
Alnylam Pharmaceuticals
 05/02/2024 10-Q 10-Q filing on 05/02/2024 View Form
ALNY
Alnylam Pharmaceuticals
 11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
ALNY
Alnylam Pharmaceuticals
 10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
ALNY
Alnylam Pharmaceuticals
 07/28/2022 10-Q 10-Q filing on 07/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 04/28/2022 10-Q 10-Q filing on 04/28/2022 View Form
ALNY
Alnylam Pharmaceuticals
 10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
ALNY
Alnylam Pharmaceuticals
 08/03/2021 10-Q 10-Q filing on 08/03/2021 View Form
ALNY
Alnylam Pharmaceuticals
 04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
ALNY
Alnylam Pharmaceuticals
 02/11/2021 10-K 10-K filing on 02/11/2021 View Form
ALNY
Alnylam Pharmaceuticals
 11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
ALNY
Alnylam Pharmaceuticals
 02/13/2020 10-K 10-K filing on 02/13/2020 View Form
ALNY
Alnylam Pharmaceuticals
 10/31/2019 10-Q 10-Q filing on 10/31/2019 View Form
ALNY
Alnylam Pharmaceuticals
 08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
ALNY
Alnylam Pharmaceuticals
 05/02/2019 10-Q 10-Q filing on 05/02/2019 View Form
ALNY
Alnylam Pharmaceuticals
 02/14/2019 10-K 10-K filing on 02/14/2019 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
ALNY
Alnylam Pharmaceuticals
 08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2018 10-Q 10-Q filing on 05/04/2018 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2018 10-K 10-K filing on 02/15/2018 View Form
ALNY
Alnylam Pharmaceuticals
 11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
ALNY
Alnylam Pharmaceuticals
 08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
ALNY
Alnylam Pharmaceuticals
 05/05/2017 10-Q 10-Q filing on 05/05/2017 View Form
ALNY
Alnylam Pharmaceuticals
 02/15/2017 10-K 10-K filing on 02/15/2017 View Form
ALNY
Alnylam Pharmaceuticals
 11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
ALNY
Alnylam Pharmaceuticals
 08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
ALNY
Alnylam Pharmaceuticals
 02/12/2016 10-K 10-K filing on 02/12/2016 View Form
ALNY
Alnylam Pharmaceuticals
 11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
ALNY
Alnylam Pharmaceuticals
 08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form
ALNY
Alnylam Pharmaceuticals
 05/08/2015 10-Q 10-Q filing on 05/08/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get ALNY Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ALNY
Sector
P/E ratio
--
24.27x
PEG ratio
--
0.00x
P/B ratio
560.95x
1.71x
Price / LTM sales
16.50x
1.71x

Growth Metrics

ALNY
Sector
Revenue growth
34.9%
6.42%
Earnings growth
--
6.3%
Revenue (5-year growth)
59.22%
9.09%
Earnings forecast
-$0.14
-$0.20

Profitability

ALNY
Sector
Profitability FY 2024
$1.9B
$56.6M
Return on invested capital
-29.16%
-14.62%
Return on assets
-6.92%
-11.82%
Return on equity
--
-16.83%

Earnings Date

Last Earnings Date
Feb
13
Next Earnings Date
May
2
Estimated Next Earnings Date
May
15

Balance Sheet

ALNY
Sector
Total cash
$2.7B
$42.5M
Short term investments
$1.7B
$37.8M
Total assets
$4.2B
$128.1M
Long term debt
$1B
$9.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Why Did Progressive Stock Go Down?
Why Did Progressive Stock Go Down?

Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…

Read article
Why Did StoneCo Stock Go Up So Much?
Why Did StoneCo Stock Go Up So Much?

Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…

Read article
Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Read article

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy or Sell?
Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy or Sell?
Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Sell
47
RGC alert for Mar 25

Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.

Buy or Sell?
Buy
58
TNXP alert for Mar 25

Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.

Buy or Sell?
Buy
54
AZEK alert for Mar 25

The AZEK [AZEK] is up 17.3% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas